Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis

Shlomit Kfir‐Erenfeld, Nathalie Asherie, Sigal Grisariu, +12

Clinical Cancer Research

Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial

Nathalie Asherie, Shlomit Kfir‐Erenfeld, Batia Avni, +13

Haematologica

Hematological MalignancyCar T CellsRadiation OncologyCell TherapyAutoimmune Disease +12

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, +9

Cancers

Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study

Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, +11

American Journal of Hematology

Early lymphocyte collection for <scp>anti‐CD19 CART</scp> production improves T‐cell fitness in patients with relapsed/refractory diffuse large B‐cell lymphoma

Tatyana Dubnikov Sharon, Miri Assayag, Batia Avni, +7

British Journal of Haematology

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival

Noa Gross Even‐Zohar, Marjorie Pick, Liron Hofstetter, +4

Journal of Clinical Medicine

ImmunologyPathologyImmunophenotypingImmunotherapyBone Marrow Pcs +14

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?

Vladimir Vainstein, Batia Avni, Sigal Grisariu, +16

Cancers

Cell TherapyWhether Cart TherapyImmunologyPathologyImmunotherapy +15

A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma

Osnat Bairey, A Taliansky, Amir Glik, +14

Cancer

Euthyroid Submedian Free T4 and Subclinical Hypothyroidism May Have a Detrimental Clinical Effect in Down Syndrome

Ariel Tenenbaum, Eyal Lebel, Sarah Malkiel, +3

Hormone Research in Paediatrics

Efficacy and Safety of Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis

Eyal Lebel, Nathalie Asherie, Shlomit Kfir‐Erenfeld, +19

Journal of Clinical Oncology